<DOC>
	<DOCNO>NCT01120405</DOCNO>
	<brief_summary>The Primary Objective show non inferiority cardiac safety ( i.e myocardial necrosis-MN- assess positive cardiac Troponin I -cTnI- ultrasensitive assay ) Xenon base general anesthesia procedure patient elevate cardiac risk schedule atherosclerotic vascular surgery ( i.e patient Coronary Arteries Disease risk ) compare sevoflurane base general anesthesia procedure , postoperatively 3 day .</brief_summary>
	<brief_title>Cardiovascular Safety Xenon General Anaesthesia , Patient With Cardiovascular Risk Non Cardiac Surgery</brief_title>
	<detailed_description>The Primary endpoint define increase 99th percentile highly sensitive cardiac Troponin I ( cTnI ) time 72 h post operatively . Time frame 3 day post-op ; Key secondary endpoint ( ) routine ( Local laboratory ) dosage standard cardiac Troponin I ( cTnI ) D1 ( 24h ) D3 ( 72 h ) post operatively , also case suspicion Myocardial Infarction , Routine cardiac safety monitoring .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Age ≥ 18 year Scheduled atherosclerotic vascular elective surgery presume fasttrack , Cardiac ischaemic risk support : History myocardial infarction old 1 month and/or Documented Stable angina ( asymptomatic ± medical treatment ) and/or History coronary revascularisation , and/or Surgical Risk Index ( `` Lee '' index ) ≥ 3 . Written inform consent Unstable angina within last 30 day , Non control arterial Hypertension . Severe Cardiac heart Failure ( NYHA IV ) Severe Chronic Obstructive Pulmonary Disease Patient already randomize another ongoing clinical trial Patient recent myocardial infarction ( M.I ) ( less one month ) Patient already include clinical trial History hypersensitivity study drug ( i.e Xenon , propofol , sevoflurane , desflurane , isoflurane ) Malignant hyperthermia Documented Elevated intracranial pressure Preeclampsia eclampsia Pregnancy lactation Presumed uncooperativeness legal incapacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Xenon</keyword>
	<keyword>Cardiac safety</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Non cardiac surgery</keyword>
	<keyword>Atherosclerotic vascular surgery</keyword>
</DOC>